Editor's Note
Surgisphere Corporation (Palatine, Illinois) on March 12 announced the availability of its new rapid diagnostic test for COVID-19 that uses artificial intelligence (AI).
With advanced machine learning, Surgisphere has developed an intelligent tool that uses three common lab tests to identify patients likely to have COVID-19 infection.
With its cloud-based healthcare data analytics platform (QuartzClinical), Surgisphere identified patients diagnosed with COVID-19 in five countries. The company then created a machine learning model using decision tree analysis and clinical and lab data on 430 patients to develop the decision support tool.
The test is now available for public use.
